Patents-Review.com
🔗 Permalink
Assignee profile:

AlphaVax, Inc.

City:

Research Triangle Park, North Carolina

Country:

United States

Published Applications:

16

Last publication date:

2016-12-29

Patent Grants:

14

Last grant date:

2018-10-30

Top Inventors for applications by AlphaVax, Inc.

These are the the leading inventors for applications assigned to AlphaVax, Inc.:

Recent patent applications by AlphaVax, Inc.

AlphaVax, Inc. based in Research Triangle Park, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2016-12-29 ✅ Patent 10,111,943 granted on 2018-10-30
US20160375124A1
Human necessities

Alphavirus replicon particles matched to protein antigens as immunological adjuvants

 #2 | 2016-12-01 ✅ Patent 10,570,416 granted on 2020-02-25
US20160348132A1
Chemistry; metallurgy

TC-83-derived alphavirus vectors, particles and methods

 #3 | 2015-10-22 ✅ Patent 9,441,247 granted on 2016-09-13
US20150299728A1
Chemistry; metallurgy

TC-83-derived alphavirus vectors, particles and methods

 #4 | 2014-07-24 ✅ Patent 9,079,943 granted on 2015-07-14
US20140205629A1
Chemistry; metallurgy

TC-83-derived alphavirus vectors, particles and methods

 #5 | 2012-08-23 ✅ Patent 8,263,092 granted on 2012-09-11
US20120213813A1
Human necessities

Alphavirus replicon particles as immunological adjuvants

 #6 | 2011-07-28 ✅ Patent 9,187,729 granted on 2015-11-17
US20110182941A1
Chemistry; metallurgy

Alphavirus and alphavirus replicon particle formulations and methods

 #7 | 2011-04-14 ✅ Patent 9,416,370 granted on 2016-08-16
US20110086062A1
Human necessities

Alphavirus replicon particles matched to protein antigens as immunological adjuvants

 #8 | 2011-02-03 ✅ Patent 8,709,441 granted on 2014-04-29
US20110027306A1
Chemistry; metallurgy

TC-83-derived alphavirus vectors, particles and methods

 #9 | 2009-03-19 ✅ Patent 7,850,977 granted on 2010-12-14
US20090075384A1
Chemistry; metallurgy

Promoterless cassettes for expression of alphavirus structural proteins

 #10 | 2009-02-19
US20090047255A1
Chemistry; metallurgy

Alphavirus and Alphavirus Replicon Particle Formulations and Methods

 #11 | 2008-09-04 ✅ Patent 8,617,533 granted on 2013-12-31
US20080213309A1
Chemistry; metallurgy

Multi-antigenic alphavirus replicon particles and methods

 #12 | 2007-07-19 ✅ Patent 7,442,381 granted on 2008-10-28
US20070166820A1
Chemistry; metallurgy

Alphavirus replicons and helper constructs

 #13 | 2006-08-10 ✅ Patent 7,425,337 granted on 2008-09-16
US20060177819A1
Chemistry; metallurgy

Alphavirus replicon vector systems

 #14 | 2006-07-18 ✅ Patent 7,078,218 granted on 2006-07-18
US10734609
-

Alphavirus particles and methods for preparation

 #15 | 2006-05-16 ✅ Patent 7,045,335 granted on 2006-05-16
US10237302
-

Alphavirus replicon vector systems

 #16 | 2005-12-01
US20050266550A1
Chemistry; metallurgy

TC-83-derived alphavirus vectors, particles and methods

Also check out AlphaVax, Inc.'s (Research Triangle Park, United States) applicant profile with 4 patent applications submitted.

AssigneeID:

72279 ⎘